Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Genotype 2 HCV in Serotype-1 Hepatitis C Patients Unresponsive to Daclatasvir plus Asunaprevir Treatment.

The Tohoku journal of experimental medicine - 1 Jan 2017

Inoue Jun, Kanno Atsushi, Wakui Yuta, Miura Masahito, Kobayashi Tomoo, Morosawa Tatsuki, Kogure Takayuki, Kakazu Eiji, Ninomiya Masashi, Fujisaka Yasuyuki, Umetsu Teruyuki, Takai Satoshi, Nakamura Takuya, Shimosegawa Tooru

Abstract excerpt

It is important to determine the genotypes or serotypes of hepatitis C virus (HCV) in patients before treatment with direct-acting antiviral agents (DAAs), because the effects of DAAs differ among genotypes. In Japan, two tests for HCV typing are available clinically, but only serotyping, not genotyping, is approved by the public health insurance. Although most serotype-1 Japanese patients are infected with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbamates
Share to Imidazoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isoquinolines

Share to Pyrrolidines

Share to Serotyping

Share to Sulfonamides

Share to Valine

Share to Viral Nonstructural Proteins

Source

Identifiers

PMID: 28049871
DOI: 10.1620/tjem.241.21

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Identification of Genotype 2 HCV in Serotype-1 Hepatitis C Patients Unresponsive to Daclatasvir plus Asunaprevir Treatment.PMID 28049871Read ↗

Prevalence of hepatitis C virus subgenotypes 1a and 1b in Japanese patients: ultra-deep sequencing analysis of HCV NS5B genotype-specific region.Semantic proximity Read ↗

Mixed HCV Infection of Genotype 1B and Other Genotypes Influences Non-response during Daclatasvir + Asunaprevir Combination Therapy.Semantic proximity Read ↗

Daclatasvir plus Asunaprevir Treatment for Real-World HCV Genotype 1-Infected Patients in Japan.Semantic proximity Read ↗

Selection of regimens for patients with hepatitis C virus genotype/serotype discrepancy.Semantic proximity Read ↗

Serologically defined genotypes of hepatitis C virus among Japanese patients with chronic hepatitis C.Semantic proximity Read ↗

[Subgenotype and serotype analysis of hepatitis B virus in Korean chronic hepatitis B patients under treatment].Semantic proximity Read ↗

Hepatitis C virus (HCV) core serotypes in chronic HCV infection.Semantic proximity Read ↗

Peginterferon Alfa-2a plus ribavirin in Japanese patients infected with hepatitis C virus genotype 2 who failed previous interferon therapy.Semantic proximity Read ↗

[Concordance between hepatitis C virus serotype and genotype in chronic hepatitis C patients in China].Semantic proximity Read ↗

A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1B.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.